PTE

PolarityTE, Inc.

2.4900
USD
10.67%
2.4900
USD
10.67%
2.1601 29.5000
52 weeks
52 weeks

Mkt Cap 183.11M

Shares Out 81.38M

Chat
Send me real-time posts from this site at my email

PolarityTE stock soars 70% on FDA regenerative medicine status to SkinTE

The U.S. Food and Drug Administration (FDA) granted regenerative medicine advanced therapy designation to PolarityTE's (NASDAQ:PTE) SkinTE under the company's open investigational new drug application (IND). The company noted that it's IND is open with the FDA and it is pursuing the first of two studies on SkinTE needed to support a biologics license application (BLA) for use of the therapy to treat chronic cutaneous ulcer. PTE +70.38% to $0.25 premarket May 13

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue